Gen AI Companies Shine In Drug Development

 
• By David Wild

A string of AI-focused deals in 2023 and two late-year gen AI-specific agreements may presage a strong 2024 for drug discovery companies employing AI. 

Bio Bytes
• Source: Shutterstock

More from Innovation

More from In Vivo